Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans

E. K. Tarkiainen, J. T. Backman, Mikko Sakari Neuvonen, P. J. Neuvonen, M. Schwab, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume92
Issue number1
Pages (from-to)68-71
Number of pages4
ISSN0009-9236
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • SINGLE-NUCLEOTIDE POLYMORPHISMS
  • PRODRUG OSELTAMIVIR
  • FINNISH POPULATION
  • PHARMACOKINETICS
  • ATORVASTATIN
  • FREQUENCIES
  • HAPLOTYPES
  • ACTIVATION
  • METABOLITE
  • GENES
  • 317 Pharmacy

Cite this

@article{28167a37967d4fcd9b2c87631a136414,
title = "Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans",
keywords = "SINGLE-NUCLEOTIDE POLYMORPHISMS, PRODRUG OSELTAMIVIR, FINNISH POPULATION, PHARMACOKINETICS, ATORVASTATIN, FREQUENCIES, HAPLOTYPES, ACTIVATION, METABOLITE, GENES, 317 Pharmacy",
author = "Tarkiainen, {E. K.} and Backman, {J. T.} and Neuvonen, {Mikko Sakari} and Neuvonen, {P. J.} and M. Schwab and Mikko Niemi",
year = "2012",
doi = "10.1038/clpt.2012.13",
language = "English",
volume = "92",
pages = "68--71",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "1",

}

Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans. / Tarkiainen, E. K.; Backman, J. T.; Neuvonen, Mikko Sakari; Neuvonen, P. J.; Schwab, M.; Niemi, Mikko.

In: Clinical Pharmacology and Therapeutics, Vol. 92, No. 1, 2012, p. 68-71.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans

AU - Tarkiainen, E. K.

AU - Backman, J. T.

AU - Neuvonen, Mikko Sakari

AU - Neuvonen, P. J.

AU - Schwab, M.

AU - Niemi, Mikko

PY - 2012

Y1 - 2012

KW - SINGLE-NUCLEOTIDE POLYMORPHISMS

KW - PRODRUG OSELTAMIVIR

KW - FINNISH POPULATION

KW - PHARMACOKINETICS

KW - ATORVASTATIN

KW - FREQUENCIES

KW - HAPLOTYPES

KW - ACTIVATION

KW - METABOLITE

KW - GENES

KW - 317 Pharmacy

U2 - 10.1038/clpt.2012.13

DO - 10.1038/clpt.2012.13

M3 - Article

VL - 92

SP - 68

EP - 71

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -